Bidirectional translational research: Progress in understanding addictive diseases
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
The focus of this review is primarily on recent developments in bidirectional translational research on the addictions, within the Laboratory of the Biology of Addictive Diseases at The Rockefeller University. This review is subdivided into major interacting aspects, including: a) Investigation of neurobiological and molecular adaptations (e.g., in genes for the opioid receptors or endogenous neuropeptides) in response to cocaine or opiates, administered under laboratory conditions modeling chronic patterns of human self-exposure (e.g., chronic escalating “binge”). b) The impact of such drug exposure on the hypothalamic-pituitary-adrenal (HPA) axis and interacting neuropeptidergic systems (e.g., opioid, orexin and vasopressin). c) Molecular genetic association studies using candidate gene and whole genome approaches, to define particular systems involved in vulnerability to develop specific addictions, and response to pharmacotherapy. d) Neuroendocrine challenge studies in normal volunteers and current addictive disease patients along with former addicts in treatment, to investigate differential pharmacodynamics and responsiveness of molecular targets, in particular those also investigated in the experimental and molecular genetic approaches described above.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stress dysregulation of drug reward pathways, and the transition to drug dependence
Koob, & Kreek, M. J. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.05030503 · Cited by 868
Self-citationDrug dependence: stress and dysregulation of brain reward pathways
Kreek, M. J., & Koob, G. F. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00064-7 · Cited by 696
Self-citationOslin, D. W., Berrettini, W., Kranzler, H. R., Pettinati, H., Gelernter, J., Volpicelli, J. R., & O'Brien, C. P. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300219 · Cited by 571 · cited 1×
“This prediction has been borne out in two studies, a non-prospective study (Oslin et al., 2003) and a large prospective study (Anton et al., 2008), which have shown that alcohol-dependent subjects with one or two copies of the 118G allele were more responsive to naltrexone pharmacotherapy.”
ResultAllelic Expression Imbalance of Human mu Opioid Receptor (OPRM1) Caused by Variant A118G
Zhang, Y., Wang, D., Johnson, A. D., Papp, A. C., & Sadée, W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504942200 · Cited by 563
Self-citationSinha, R., Garcia, M., Paliwal, P., Kreek, M. J., & Rounsaville, B. J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.324 · Cited by 528 · cited 2×
“…and colleagues at Yale of the impact of individualized narratives on either stress- or drug-related topics, on cocaine craving and on objective measurements of the HPA response, and then followed up subjects after release from a protected clinical research inpatient setting (Sinha et al., 2006).”
BackgroundSelf-citationAnton, R. F., Oroszi, G., O’Malley, S., Couper, D., Swift, R., Pettinati, H., & Goldman, D. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.2.135 · Cited by 451 · cited 1×
“This prediction has been borne out in two studies, a non-prospective study (Oslin et al., 2003) and a large prospective study (Anton et al., 2008), which have shown that alcohol-dependent subjects with one or two copies of the 118G allele were more responsive to naltrexone pharmacotherapy.”
ResultPharmacogenetics and Human Molecular Genetics of Opiate and Cocaine Addictions and Their Treatments
Kreek, M. J., Bart, G., Lilly, C., Laforge, K. S., & Nielsen, D. A. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.1 · Cited by 391
Self-citationInvolvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal
Georgescu, D., Zachariou, V., Barrot, M., Mieda, M., Willie, J. T., Eisch, A. J., Yanagisawa, M., Nestler, E. J., & DiLeone, R. J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03106.2003 · Cited by 373 · cited 1×
“Most of the lateral hypothalamus orexin neurons express the preprodynorphin (ppDyn) gene, and around half of lateral hypothalamus orexin neurons also express mu-opioid receptors (Chou et al., 2001; Georgescu et al., 2003).”
BackgroundDOLE, V. P. (1966) · Archives of Internal Medicine · doi:10.1001/archinte.1966.00290160004002 · Cited by 290
Medical safety and side effects of methadone in tolerant individuals
Kreek, M. J. (1973) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1973.03220060039009 · Cited by 247 · cited 2×
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript al., 1980), and, in contrast, a long half-life of 24 to 28 hours in humans for the racemic mixture as is used in most human pharmacotherapy and in most, but not all, rodent studies (Kreek, 1973b).”
BackgroundMethodSelf-citationKroslak, T., LaForge, K. S., Gianotti, R. J., Ho, A., Nielsen, D. A., & Kreek, M. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04738.x · Cited by 213 · cited 2×
“It has also been reported that the A118G allele expresses approximately one-half the OPRM1 mRNA and about one-tenth the mu-opioid receptor protein (Beyer et al., 2004; Zhang, Wang, et al., 2005; Kroslak et al., 2007).”
BackgroundSelf-citationKreek, M. J., Wardlaw, S. L., Hartman, N., Raghunath, J., Friedman, J., Schneider, B., & Frantz, A. G. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90529-5 · Cited by 92
Self-citationBart, G., Piccolo, P., Zhang, L., Jacobson, I., Schaefer, R. A., & Kreek, M. J. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02151.x · Cited by 25 · cited 2×
“D. Studies of Hepatitis A, B and C in Former Opiate Addicts in Methadone Maintenance Treatment We have made a novel finding, the unexpected presence of hepatitis B DNA, that is, “silent hepatitis B,” in clinically well patients (Bart et al., 2008).”
BackgroundSelf-citation
Cited by
The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors
Bruchas, M. R., Land, B. B., & Chavkin, C. (2010) · Brain Research · doi:10.1016/j.brainres.2009.08.062 · Cited by 544
“One of the primary mechanisms for relapse to drug seeking in humans is stress exposure (Kreek et al., 2009).”
BackgroundPharmacotherapy in the Treatment of Addiction: Methadone
Kreek, M. J., Borg, L., Ducat, E., & Ray, B. (2010) · Journal of Addictive Diseases · doi:10.1080/10550881003684798 · Cited by 108
“This difference occurred in a series of studies in which we used the shortened form of the dynorphin A(1-13) of the natural kappa opioid ligand dynorphin A(1-17), approved for use under an FDA investigator-initiated IND, to probe the tuberoinfundibular dopaminergic system.”
BackgroundMethodSelf-citationKowalczyk, W. J., Phillips, K. A., Jobes, M. L., Kennedy, A. P., Ghitza, U. E., Agage, D. A., Schmittner, J. P., Epstein, D. H., & Preston, K. L. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14081014 · Cited by 101
Zhou, Y., Proudnikov, D., Yuferov, V., & Kreek, M. J. (2010) · Brain Research · doi:10.1016/j.brainres.2009.11.015 · Cited by 58
Self-citation
Metadata
- Authors
- Kreek, M. J., Schlussman, S. D., Reed, B., Zhang, Y., Nielsen, D. A., Levran, O., Zhou, Y., & Butelman, E. R.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2009-01
- Volume
- 56
- Pages
- 32-43
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W1989710212
- Cited by
- 28
- References
- 13
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.